Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Emodin (Standard)
Cat. No.:
OB0425LY-404
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Emodin is an anti-SARS-CoV compound that inhibits casein kinase-2 (CK2). It has Anti-inflammatory and anticancer effects.
Synonyms:
518-82-1; Emodol; Frangula emodin; Schuttgelb; 1,3,8-Trihydroxy-6-methylanthracene-9,10-dione; Rheum emodin; 9,10-Anthracenedione, 1,3,8-trihydroxy-6-methyl-; 6-Methyl-1,3,8-trihydroxyanthraquinone
CAS No.:
518-82-1
Compound CID:
3220
Formula:
C15H10O5
Formula Weight:
270.24
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Emodin (Standard) can be used for anti-cancer research, liver protection research, cardiovascular system research and drug development.
